Brief: Dishman Carbogen Amcis Says Bavla Site Has Been Declared Gmp Compliant By Japanese Pharmaceuticals And Medical Devices Agency
23/01/2024 14:32
Jan 23 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS :
* BAVLA SITE HAS BEEN DECLARED GMP COMPLIANT BY JAPANESE PHARMACEUTICALS AND
MEDICAL DEVICES AGENCY
Further company coverage: DSHM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis